info@seagull-health.com
SeagullHealth
语言:
search

Who can use Velsipity(Etrasimod)?

This medication is indicated for treating adults with moderately to severely active ulcerative colitis.

Approved Indication

VELSIPITY is specifically approved for the treatment of moderately to severely active ulcerative colitis in adult patients. It is used to manage the chronic inflammation of the colon and rectum that characterizes this form of inflammatory bowel disease, helping to achieve and maintain clinical remission.

Etrasimod(Velsipity)
Etrasimod(Velsipity)
Used to lower LDL-C and reduce cardiovascular risk in adults who cannot...
WeChat Scan
Free Inquiry
Related articles
共 0 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved